Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Lenvima 10mg Capsules contain the active ingredient Lenvatinib, a targeted therapy used in the treatment of various cancers, including thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. Lenvatinib is classified as a kinase inhibitor and works by inhibiting proteins that stimulate cancer cell proliferation.
Dosage:
Lenvima 10mg Capsule is administered orally once daily, at a consistent time each day, with or without food. The specific dosage may vary depending on the patients medical condition and treatment response. It is crucial to adhere to the dosage guidelines provided by your healthcare provider.
Usage:
Lenvima 10mg Capsules are indicated for the treatment of: